The clinicopathological significance of basal markers in early-stage invasive carcinoma of no special type of the breast | Zendy

Fikret Dirilenoğlu | Zendy; Demet Etıt | Zendy; Halil Taşkaynatan | Zendy; Ferhan Elmalı | Zendy

Open Access

The clinicopathological significance of basal markers in early-stage invasive carcinoma of no special type of the breast

Author(s) -

Fikret Dirilenoğlu,

Demet Etıt,

Halil Taşkaynatan,

Ferhan Elmalı

Publication year - 2020

Publication title -

turkish journal of pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.305

H-Index - 14

eISSN - 1309-5730

pISSN - 1018-5615

DOI - 10.5146/tjpath.2020.01487

Subject(s) - medicine , basal (medicine) , cytokeratin , breast cancer , oncology , immunohistochemistry , stage (stratigraphy) , breast carcinoma , progesterone receptor , epidermal growth factor receptor , pathology , cancer , estrogen receptor , biology , paleontology , insulin

Basal markers [cytokeratin 5/6 (CK5/6) and epidermal growth factor receptor (EGFR)] are used in identifying the basal-like breast carcinoma subtype, which is associated with a poor prognosis. However, the clinicopathological significance in early-stage invasive carcinoma of no special type (IC, NST) has not been well established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research